Moderna Reaches Analyst Target Price
In recent trading, shares of Moderna Inc (Symbol: MRNA) have crossed above the average analyst 12-month target price of $46.62, changing hands for $49.70/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuatio
In recent trading, shares of Moderna Inc (Symbol: MRNA) have crossed above the average analyst 12-month target price of $46.62, changing hands for $49.70/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuatio